A hidden Markov model to assess drug-induced sleep fragmentation in the telemetered rat

Drug-induced sleep fragmentation can cause sleep disturbances either via their intended pharmacological action or as a side effect. Examples of disturbances include excessive daytime sleepiness, insomnia and nightmares. Developing drugs without these side effects requires insight into the mechanisms leading to sleep disturbance. The characterization of the circadian sleep pattern by EEG following drug exposure has improved our understanding of these mechanisms and their translatability across species. The EEG shows frequent transitions between specific sleep states leading to multiple correlated sojourns in these states. We have developed a Markov model to consider the high correlation in the data and quantitatively compared sleep disturbance in telemetered rats induced by methylphenidate, which is known to disturb sleep, and of a new chemical entity (NCE). It was assumed that these drugs could either accelerate or decelerate the transitions between the sleep states. The difference in sleep disturbance of methylphenidate and the NCE were quantitated and different mechanisms of action on rebound sleep were identified. The estimated effect showed that both compounds induce sleep fragmentation with methylphenidate being fivefold more potent compared to the NCE.

[1]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[2]  B Kemp,et al.  Simulation of human hypnograms using a Markov chain model. , 1986, Sleep.

[3]  A. Rechtschaffen,et al.  NREM sleep with low-voltage EEG in the rat. , 1987, Sleep.

[4]  Sheldon M. Ross.  Introduction to Probability Models. , 1995 .

[5]  A. Swann,et al.  Dose response characteristics of methylphenidate on different indices of rats' locomotor activity at the beginning of the dark cycle , 1996, Brain Research.

[6]  N J Douglas,et al.  The effect of sleep fragmentation on daytime function. , 1996, American journal of respiratory and critical care medicine.

[7]  Meindert Danhof,et al.  A pharmacodynamic Markov mixed‐effect model for the effect of temazepam on sleep , 2000, Clinical pharmacology and therapeutics.

[8]  N. Volkow,et al.  Synergistic interactions between nicotine and cocaine or methylphenidate depend on the dose of dopamine transporter inhibitor , 2000, Synapse.

[9]  D. Bates,et al.  Mixed-Effects Models in S and S-PLUS , 2001 .

[10]  G. Gregory,et al.  A two-state stochastic model of REM sleep architecture in the rat. , 2002, Journal of neurophysiology.

[11]  R. Jakus,et al.  Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity, and sleep: changes at the light–dark phase shift , 2002, Brain Research.

[12]  Y. Matsue,et al.  Model insomnia by methylphenidate and caffeine and use in the evaluation of temazepam , 2004, Psychopharmacology.

[13]  M. Ivarsson,et al.  Antidepressants and REM sleep in Wistar-Kyoto and Sprague-Dawley rats. , 2005, European journal of pharmacology.

[14]  Shelly Crisler,et al.  Sleep-stage scoring in the rat using a support vector machine , 2008, Journal of Neuroscience Methods.

[15]  R. Müller,et al.  Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology. , 2008, International journal of pharmaceutics.

[16]  Giuseppe De Nicolao,et al.  Multinomial logistic estimation of Markov-chain models for modeling sleep architecture in primary insomnia patients , 2010, Journal of Pharmacokinetics and Pharmacodynamics.

[17]  Mats O. Karlsson,et al.  Modeling Sleep Data for a New Drug in Development using Markov Mixed-Effects Models , 2011, Pharmaceutical Research.

[18]  Giuseppe De Nicolao,et al.  Multinomial Logistic Functions in Markov Chain Models of Sleep Architecture: Internal and External Validation and Covariate Analysis , 2011, The AAPS Journal.